Terrence W. Norchi

CEO of Arch Therapeutics, Inc.

Terrence W. Norchi, MD is president and CEO of Framingham, MA-based Arch's flagship development stage product candidate, the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.

Want to write for 麻豆社 too? Apply to join 麻豆社 Leadership network.

More From Terrence W. Norchi

More Authors You Might Like